Related Experiment Video
Updated: Jul 8, 2026

A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
Cerebral venous sinus thrombosis in children: a multicenter cohort from the United States
Mohammad Wasay1, Alper I Dai, Mohsin Ansari
1Aga Khan University, Karachi, Pakistan. mohammad.wasay@aku.edu
Insights
Pediatric cerebral venous thrombosis (CVT) primarily impacts infants under six months. Neonatal CVT carries a high mortality rate, and many survivors experience neurological deficits, highlighting treatment gaps.
Area of Science:
- Pediatric Neurology
- Vascular Neurology
- Child Health
Background:
- Cerebral venous thrombosis (CVT) is a significant cause of stroke in children.
- Understanding the epidemiology and clinical spectrum of pediatric CVT is crucial for improved outcomes.
Purpose of the Study:
- To analyze clinical findings, risk factors, and outcomes in a large multicenter cohort of children with CVT.
- To identify prognostic indicators and evaluate current treatment strategies for pediatric CVT.
Main Methods:
- Retrospective analysis of 70 pediatric patients diagnosed with CVT across 5 US centers.
- Data collection included demographics, clinical presentation, neurological findings, predisposing factors, imaging, treatment, and outcomes.
Main Results:
- CVT predominantly affected infants (<6 months), with seizures and coma being common presentations.
- Infection and perinatal complications were the most frequent predisposing factors.
- Hemorrhagic infarcts occurred in 40%, and mortality was 13% overall, reaching 25% in neonates. Only 25% received anticoagulation or thrombolysis.
Conclusions:
- Pediatric CVT is a serious condition, particularly in neonates, with significant morbidity and mortality.
- Seizures and coma at presentation are associated with poor prognosis.
- Underutilization of anticoagulation and thrombolysis suggests a need for optimized treatment protocols.
Abstract:
This study presents a large multicenter cohort of children with cerebral venous thrombosis from 5 centers in the United States and analyzes their clinical findings and risk factors. Seventy patients were included in the study (25 neonates, 35%). The age ranged from 6 days to 12 years. Thirty-eight (55%) were younger than 6 months of age, and 28 (40%) were male. Presenting features included seizures (59%), coma (30%), headache (18%), and motor weakness (21%). Common neurological findings included decreased level of consciousness (50%), papilledema (18%), cranial nerve palsy (33%), hemiparesis (29%), and hypotonia (22%). Predisposing factors were identified in 63 (90%) patients. These included infection (40%), perinatal complications (25%), hypercoagulable/hematological diseases (13%), and various other conditions (10%). Hemorrhagic infarcts occurred in 40% of the patients and hydrocephalus in 10%. Transverse sinus thrombosis was more common (73%) than sagittal sinus thrombosis (35%). Three children underwent thrombolysis, 15 patients received anticoagulation, and 49 (70%) were treated with antibiotics and hydration. Nine (13%) patients (6 of them neonates) died. Twenty-nine patients (41%) were normal, whereas 32 patients (46%) had a neurological deficit at discharge. Seizures and coma at presentation were poor prognostic indicators. In conclusion, cerebral venous thrombosis predominantly affects children younger than age 6 months. Mortality is high (25%) in neonatal cerebral venous thrombosis. Only 18 (25%) patients were treated with anticoagulation or thrombolysis.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Cerebral Edema ll: Pathophysiology
Venous Thrombosis III: Interprofessional Care
Hemorrhagic Stroke ll: Pathophysiology
Aneurysm II: Clinical Manifestations and Diagnostic Studies